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Purine nucleotide cycle in rat renal cortex and medulla under condi-
tions that mimic normal and low oxygen supply. The distinctive feature of
the renal function and metabolism implicate a possibility of excessive ATP
degradation during insufficient oxygen supply. Protection of the purine
ring against degradation is one among other functions of the purine
nucleotide cycle (PNC). The purpose of this study was to estimate the
activity of PNC in cytosol of rat renal cortex and medulla under conditions
that mimic normal and low oxygen supply in vivo. In normoxic-like
condition the rate of AMP deamination was 1.7 and 2.0 nmol/mg
protein/mm in the cytosol of cortex and medulla, respectively. Under this
condition, the rate of IMP reamination was similar to that of AMP
deamination. In a hypoxia-like condition the rate of AMP deamination
increased by 41% in cytosot from both parts of the kidney, while the rate
of IMP reamination remained unchanged in the cytosol of medulla and
decreased by 46% in the cortex cytosol. Distribution of the other enzymes
of the PNC, that is, adenylsuccinate synthetase and adenylosuceinate
lyase, in the cytosol of cortex and medulla correlated with that observed
for AMP deamination and IMP reamination potentials. At 150 /.LM IMP,
the activity of adenylosuceinate synthetase in the cortex and medulla was
0.34 and 1.24 nmol/mg protein/mm, respectively. Activity of the adenylo-
suceinate lyase was severalfold greater than the respective activity of the
adenylosuccinate synthetase. These results show that the efficiency of PNC
is about twice as high in the medulla cytosol as in the cortex cytosol, and
that the activity of PNC in kidney is mainly limited by the activity of
adenylosuccmnate synthetase and supply of AMP.
the opposite reaction in the PNC, that is, reamination of IMP to
AMP is almost twice as high in the medulla as in the cortex [9, 10,
13]. Again, activity of the adenylosuccinate synthetase, the key
enzyme of IMP reamiriation, is strongly regulated by some purine
nucleotides [19—22]. The purine nucleotide cycle in the kidney
plays fundamental role in protecting the purine ring against
degradation. However, the unique function of the kidney impli-
cates other significant physiological possibilities for this cycle: (i)
generation of ammonia for renal hydrogen ion excretion; (ii)
generation of ammonia and fumarate, which improves efficiency
and cooperativity between glycolysis and Krebs cycle; and (iii)
regulation of the tissue AMP level, the main source of adenosine
in the kidney.
The purpose of our study was to estimate the activity of the
whole purine nucleotide cycle in cytosol of rat renal cortex and
medulla under conditions that mimic normal and low oxygen
supply. The results show that the efficiency of PNC in the cytosol
from medulla is about twice as high as in the cortex cytosol, and
that the activity of PNC in kidney is mainly limited by the activity
of adenylosuceinate synthetase and the supply of AMP.
Methods
Cytosol preparation
Distinctly lower blood flow and oxygen supply characterize a
function of the renal medulla [1—3], which implicates the possi-
bility of excessive ATP degradation in medulla during hypoxia,
ischemia or overload of transport processes. AMP, the main
mid-product of the ATP catabolism, can be dephosphotylated to
adenosine, which plays crucial role in the regulation of glomerular
function [4—8]. However, the predominant quantity of AMP is
metabolized to IMP, which is subsequently dephosphorylated to
inosine or can be reaminated to AMP through the purine
nucleotide cycle (PNC) [9—12]. A higher risk of ATP degradation
in the medulla than in the cortex suggests a higher activity of the
PNC in this part of kidney. Indeed, the deamination step, which
depends on the activity of the AMP-deaminase, seems to be more
efficient in the medulla [10, 12, 13]. The physiological interpreta-
tion of this fact is very difficult because this enzyme has allosteric
properties and is regulated by several factors [14—18]. Activity of
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Male Wistar rats weighing 200 to 250 g and fed with standard
laboratory diet were anesthetized with nembutal (40 mg per kg
body wt). After perfusion in situ with cold saline, the kidneys were
removed and dissected for cortex and medulla. Tissues were
homogenized in four volumes of ice-cold extraction buffer con-
taining 30 ma't imidazole-HCI, pH 7.4, 8 mjvt K2HPO4, 50 mrvi KCI,
1 mM EDTA, 0.25 mivi dithiothreitol. Homogenate were centri-
fuged twice at 0 to 4°C: at 30,000 X g for 10 minutes and
subsequent supernatant at 100,000 X g for 60 minutes. Resulting
cytosol was deprived of low molecular weight molecules by
chromatography on a Sephadex G-50 column (1.5 X 25 cm)
equilibrated with the extraction buffer. Fractions containing the
highest concentrations of protein were pooled and used in the
experiments.
Incubation conditions
Unless otherwise indicated, the basic reaction mixture con-
tained 30 mrvt imidazole-HCI, pH 7.4, 50 m'vi KCI, 8 mat phos-
phates, 1 mat EDTA, 10 mat MgCl2, 2 J.LM coformycin, 2 mat ATP,
0.3 mM GTP, 2 mat L-aspartate and 18 mg of cytosol protein per
assay. Reaction was started by the addition of ATP and was run in
a final volume of 6 ml at 37°C. The reaction was stopped after 0,
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10, 30, 60 and 120 minutes by withdrawal of 500 pi of the reaction
mixture and adding it to 100 jxl of 3 M perchloric acid (PCA) or
100 d of 1.8 M trichloroacetic acid (TCA). Acidified samples were
incubated for 30 minutes at 0 to 4°C, spun for five minutes
(12,000 X g) and the resultant supernatant was used for assay of
metabolites. The experiments were performed with and without
the ATP regenerating system (R). For ATP to be regenerated in
the incubation medium (R) was included 0.3 mg of creatine
phosphokinase (CPK) and 15 mM phosphocreatine.
Assays
Ammonia was measured in the TCA-supernatant using a
modification of a chemical method [23]. An assay of the adenosine
by RIA method [241 was performed in neutralized TCA-superna-
tant (extracted 4 times with 5 volumes of a water-saturated ethyl
ether). ATP and all other metabolites were measured in the
neutralized PCA-supernatant (KOH 5 M followed by K2C01 2 M)
by methods based on an enzymatic analysis [251: ATP, using
glucose-6-phosphate dehydrogenase and hexokinase; ADP and
AMP, using lactate dehydrogenase, pyruvate kinase and myoki-
nase; IMP and its metabolites (IHXU = inosine + hypoxanthine
+ xanthine + uric acid), using uricase, xanthine oxidase, nucleo-
side phosphorylase and alkaline phosphatase. Protein was deter-
mined by the method of Lowry et al [26].
Enzyme assay
Cytosof from the renal cortex and medulla were prepared as
above except of the buffer used, which contained 50 mvt HEPES-
KOH, pH 7.3, 1 mivi MgCI7, 0.1 msi dithiotreitol. Activity of the
adenylosuccinate lyase was measured in the same buffer and in the
presence of different adenylosuccinate (AMPS) concentrations.
The activity of adenylosuccinate synthetase was assayed in the
medium containing: 50 ms'i HEPES-KOH, pH 7.3, 8 mrvi MgC12,
10 mM KCI, 4 m'vi L-aspartate, 0.1 mvt GTP, 0.4 mrvi phosphoenol-
pyruvate, 3 U/ml pyruvate kinase and different IMP concentra-
tions. The rate of both reactions was measured in a final volume
of 1 ml at 37°C and at a wavelength of 280 urn using the Aminco
DW-2 speetrophotometer. The activity of the enzymes was calcu-
lated from the difference in the molar absorption coefficients of
AMP and AMPS (11.7 x i0 M cm').
Statistical analysis
The metabolite concentration and rate of its conversion are
expressed as a mean (x) SEM from at least four experiments. The
non-parametric Wilcoxon paired test was used for statistical
analysis.
Reagents
ATP, AMP, GTP, CPK and all other enzymes were obtained
from Boehringer (Mannheim, Germany); dithiotreitol, L-aspar-
tate and coformycin from Calhiochern-Hoechst (San Diego, CA,
USA); ATP and GTP from Sigma Chemical Co. (St. Louis, MO,
USA); dithiotreitol and Dowex AG 50 X 8 from Serva (Heidel-
berg, Germany); creatine phosphate and HEPES from Merck
(l)armstadt, Germany); IMP from Pabs Laboratories (Milwau-
kee, MN, USA); Sephadex G-50 from Pharmacia (Uppsala,
Sweden).
Results
ATP added to the incubation medium was intensively metabo-
lized to AMP (Fig. 1B) with a transient increase in ADP accumu-
lation (Fig. 1A). Similar changes and a parallel loss of the adenine
nucleotide pool (Table 1) have been observed in the cortex and
medulla. Such a situation basically mimics in vivo oxygen defi-
ciency ("hypoxia"). The addition of the ATP-regenerating mixture
to the medium stabilizes, at least for 60 minutes, concentrations of
all of the adenine nucleotides (Fig. I C, D). Under the conditions
employed, the concentration of ATP was maintained at 2 mM,
while ADP and AMP remained at 0.4 and 0.2 m, respectively.
Such conditions are similar to the normal oxygen supply in vivo
("normoxia"). In the presence and absence of ATP regenerating
system a significant quantity of ammonia was generated that
exceeded the utilization of adenine nueleotide (Table 1). The
presence of coformycin in the incubation medium at a concentra-
tion that exclusively inhibits adenosine deaminase suggests that
the main source of ammonia was AMP. To answer the question of
whether adenine nucleotide (AMP) is the only substrate for
ammoniagenesis, control experiments with AMP alone and IMP
with the ATP-regenerating mixture (IMP+R) as the substrate
were performed (Fig. 2). In the presence of AMP, the quantity of
ammonia produced was similar to the utilization of AMP and
indicates that ammonia is mainly generated from this nucleotide.
The difference in ammonia production between cortex and me-
dulla could be due to the absence of ATP, which is very strong
activator of AMP-aminohydrolase [14—18]. Incubation of cytosol
with IMP+R resulted in the generation of adenine nucleotide
(mainly ATP) without concomitant ammonia production. There-
fore, sources of ammonia other than AMP can be excluded. It can
be assumed that in the conditions in this study, the increase in the
ammonia level generally reflected the amount of AMP deami-
nated.
AMP — IMP = L Ammonia
Consequently, the difference between the quantity of NH3 pro-
duction and the sum of IMP with inosine + hypoxantine +
xantine + uric acid (IMP + IHXU) level defined the quantity of
IMP rearninated to AMP.
IMP —AMP = Ammonia (IMP + IHXU)
Data presented in Table 2 show that both processes were mar-
ginally affected by 2 jIM coformycin. In the presence of ATP alone,
coformycin inhibited ammoniagenesis by about 25% with no
significant influence on the quantity of reaminated IMP [ammo-
nia — (IMP + IHXU)]. Moreover, the decrease in IMP+IHXU
and increase in adenosine levels correlated with these results. In
the medium supplemented with the ATP-regenerating mixture,
coformycin did not significantly affect ammoniagenesis, and the
accumulation of IMP, IHXU and adenosinc has not been ob-
served. In such conditions the process of IMP reamination was not
affected significantly by eoformycin (Table 2). Thus, it can be
assumed that 2 jIM coformiein nearly completely inhibits deami-
nation of adenosine and only slightly suppresses the processes
involved in purine nucleotide cycle.
The metabolism of ATP in the cytosol of renal cortex and
medulla after 60 minutes of incubation are shown in the Table 1.
In the presence of ATP alone a similar quantity of AMP was
deaminated in both parts of the kidney. Originated from this
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Substrate
ATP ATP +R
Cortex Medulla Cortex Medulla
ATP+ADP+AMP
Ammonia
IMP
II-{XU
NH1-(IMP+IHXU)
—0.43 0.27
0.45 0.07
0.16 0.03
0.018±0.004
0.27 0.05
—0.25 0.16
0.49 0.05
0.06 0.04a
0.010±0.002
0.43 0.07
0.02 0.13
0.34 0.04
<0.005
<0.002
0.34 0.04
0.05 0.24
0.37 0.07
<0.005
<0.002
0.35 0.07
Cytosol was incubated for 60 minutes in the presence of 2 mM ATP
(ATP) or 2 mrvi ATP with ATP regenerating mixture (ATP + R). Details
are in the Methods Section. Data are expressed in mmol/liter as a
difference between 0 and 60 mm of incubation (N = 5). IHXU is a sum of
inosine, hypoxanthine, xanthine and uric acid.
P < 0.05 medulla vs. cortex
1.0
0.5
0.0
—4-—i Fig. 1. ATP metabolism in the rat renal cortex
(0) and medulla (•). Cytosol was incubated in
the presence of 2 mi ATP (A and B) and 2
mM ATP with ATP regenerating mixture (C
and D). Details are in the Methods section.
EL—
AMP IMP+R
Fig. 2. Metabolism of adenine nucleotides and ammonia generation in rat
renal cortex (E) andmedulla (. ytosol was incubated for 60 minutes in
the presence of 1 mrvi AMP (AMP) or in the presence of 0.3 mM IMP and
0.3 ms ATP with ATP regcneratig mixture (IMP + R). Significant
difference betwen cortex and medulla (P < 0.05) is marked by asterix.
ADN is a sum of ATP + ADP + AMP.
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Table 1. Metabolism of ATP in the rat renal cortex and medulla * 0.5
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process, IMP was reaminated by 85 6% in the medulla and by
only 58 5% in the cortex (P < 0.01). The quantity of reaminated
IMP was very close to the quantity of adenine nucleotide synthe-
sized in the presence of IMP and ATP-regenerating mixture (Fig.
2; IMP+R). In both types of experiments reamination of IMP in
the medulla exceeds by 60% that observed in cortex. These results
indicate that in hypoxia-like conditions efficiency of the purine
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Table 2. Effect of coformicin on ATP metabolism in rat renal cortex and medulla
Cof.
Substrate
ATP ATP +R
Cortex MedullaCortex Medulla
Ammonia
IMP + IHXU
Ammonia-(IMP +
Adenosine
IHXU)
—
+
—
+
+
—
+
0.61 0.04
0.45 0.07
0.46 0.04
0.18 0.03
0.15 0.06
0.27 0.05
<0.001
0.026 0.004
0.60 0.11
0.49 0.05
0.21 0.07
0.07 0.04'
0.39 0.lla
0.43 0.07
<0.001
0.025 0.004
0.41 0.07
0.34 0.04
<0.01
<0.01
0.40 0.08
0.34 0.04
<0.001
<0.001
0.41 it 0.08
0.37 0.07
<0.01
<0.01
0.40 0.08
0.35 0.07
<0.001
<0.001
Cytosol was incubated for 60 mm in the presence of 2 mat ATP (ATP) or 2 m ATP with ATP regenerating mixture (ATP+R) in the presence and
absence of 2 /LM coformycin (Cof.) as described in the Methods section. Data are expressed in mmol/liter as a difference between 0 and 60 mm of
incubation (N = 5). IHXU is a sum of inosine, hypoxanthine, xanthine and uric acid.
aP < 0.05, medulla vs. cortex
L
E
E
[IMP —-AMP] TI,
T —
30 60
Fig. 3. Rate of AMP deamination and IMP
reamination in the rat renal cortex (0) and
medulla (•). Cytosol was incubated in theVU presence of 2 mvi ATP (A and B) and 2 mM
ATP with AlP regeneratig mixture (C and D).
Details are in the Methods section.
nucleotide cycle is mainly limited by the activity of TMP-reami-
nating enzymes and the process is much more effective in medulla.
Supplementation of the incubation medium with ATP-regener-
ating mixture (Table 2; ATP + R) decreased ammonia levels by
25%, similarly in both parts of the kidney. Practically all synthe-
sized IMP was reversibly reaminated to AMP and pool of the
adenine nucleotide was unchanged. Lack of adenosine (Table 2)
and IHXU (Table 1) accumulations suggests that AMP in nor-
moxie-like conditions is metabolized only through purine nucleo-
tide cycle, the efficiency of which mainly depends on the activity of
AMP deaminase and the supply of AMP.
This observation was confirmed by measuring the levels of
ammonia after 10, 30 and 60 minutes of incubation (Fig. 3A, C).
It may he assumed that inclination of the correlation curves
reflects actual activity of AMP deaminase. Thus, the rate of IMP
reamination was calculated from the difference between ammonia
and IMP+IHXU levels (Fig. 3 B, D). The summarized data are
shown in Table 3. Activites of AMP deaminase are similar in both
[AMP — IMP]
B
1'
/ 0.4
0.2
0.0
0
E
L.
0
E
E
0 30
C
0.4
0.2
0.0
0.4
0.2
0.0
60 0
0
[AMP —' IMP]
0.4
0
E
E
[IMP —3-AMP]
0.2
0 30 60 0
0.0
Time of incubation, minutes
30
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Cortex Medulla Cortex Medulla
AMP — IMP 2.4 0.2 2.4 0.2 1.7 0.2 2.0 0.3
IMP —* AMP 1.3 0.2 2.1 O.4' 1.6 0.2 2.0 0.4
Cytosol was incubated in the presence of 2 mM ATP (ATP) or 2 mM
ATP with ATP regenerating mixture (ATP + R). Details are in the
Methods section. Activity of deamination (AMP — IMP) was calculated
from the rate of ammonia generation. Activity of reamination (IMP —b
AMP) was calculated from the difference between ammonia and
IMP+IHXU. IHXU is a sum of inosine, hypoxanthine, xanthine and uric
acid. Data are expressed in nmol/mg protein/mm (N = 5).
'P < 0.05 ATP vs. ATP + R, P < 0.05 Cortex vs. medulla
AMPS,,UM
Fig. 4. Activity of (A) AMPS synihetase and (B) AMPS lyase in (he rat renal
Cortex (0) and medulla (•). Assay conditions were as described in the
Methods section. The results are mean values for 3 determinations on 3
different cytosol preparations SI).
experimental conditions and achieve practically the same effi-
ciency in the cortex and medulla, about 2 nmol!mg protein/mm.
The efficiency of IMP reamination in medulla was close to this
value, while in the cortex this process was distinctly limited and in
Enzyme Substrate Cortex Medulla
AMPS-synthetase
IMP
Km
—
180 15
3.10 0.03
AMPS-lyase
AMPS
Km
Vrna
5.0 0.9
1.11 0.04
2.8 0.4
22.5 1.2
the presence of ATP alone achieved only 1.3 nmol/mg protein!
mm.
Presented data as well as previous observations [9, 121 suggest
that activity of the IMP-reaminating enzymes limit efficiency of
the purine nucleotide cycle. The activity of both enzymes involved
in this process, adenylosuccinate (AMPS) synthetase and adenyl-
osuccinate lyase are shown in Figure 4 and the kinetic data are
summarized in Table 4. The graphic representation of the activity
of medullary AMPS synthetase has regular hyperbolic shape up to
150 p.M IMP and higher concentrations of nucleotide inhibits this
enzyme. Activity of this enzyme in cortex was several times lower
than in medulla, what allowed us to perform assays only at optimal
150 /.LM IMP concentration and were 0.32 + 0.06 and 1.24 + 0.04
nmol!mg of protein/mm in cortex and medulla, respectively.
Regular hyperbolic curves have been also observed for AMPS
lyase. Activity of this enzyme was twenty times higher in medulla
than in cortex and significantly exceeds respective activity of
AMPS synthetase. The K, values for AMPS lyase in both part of
the kidney were as low as 5 p.M AMPS, while Km for AMPS
synthetase attained almost 0.2 mrvi IMP. These data strongly
confirm that activity of the AMPS synthetase is a rate-limiting step
in the purine nucleotide cycle in the kidney.
Discussion
1.5 The data presented lead to the basic observation that the
medulla possesses a greater efficiency of the purine nucleotide
cycle than the cortex. This difference was particularly apparent in
1.0 the condition that simulated a decrease in the oxygen supply.
Calculated activities of PNC in hypoxic-like conditions (2.1 and
1.3 nmol/mg protein/mm in medulla and cortex, respectively) are
0 5 close to the rate of IMP reamination in the rat renal cortex and
medulla measured previously by the radiochemical method [91,
and correlate with the kinetic parameters of adenylosuccinate
(AMPS) synthasc (Table 1). In the kidney this enzyme is charac-
0.0 terized by having the lowest activity in PNC as well as by relatively
high Km values for IMP and aspartate [9, 12, 271. Activity of the
AMPS-lyase exceeds the activity of the synthase by several times.
Moreover, AMPS-lyase has a low K, for adenylosuccinate [12,
27]. In agreement with the kinetic parameters of these enzymes
are data indicating that in cytosol incubated in the presence of
IMP and the ATP-regenerating mixture, only a slight accumula-
tion of adenylosuccinate has been observed [10]. The third
enzyme of the purine nucleotide cycle, AMP deaminase shows the
highest activity (12, 27, 28]. However, this enzyme is characterized
by very high O5 values for AMP and is allosterically modulated by
several factors like purine nucleotides, potassium or phosphate
[13—18]. Accumulation of IMP in hypoxic-like conditions (Table
1) suggests that the activity of AMP deaminase is not the rate
Table 3. Activity of the purine nucleotide cycle in the cytosol of rat
renal cortex and medulla
Substrate
ATP ATP+R
Table 4. Kinetic constants of AMPS synthetase and AMPS lyase in the
cytosol of rat renal cortex and medulla
A
Assay conditions were as described in the Methods section. Data are
expressed in (mM (Kr,) and nmol/mg prot/min (Vmx) and are mean values
for 3 determinations on 3 different cytosol preparations se
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limiting reaction in PNC. However, in the normoxic-like situation
activity of this enzyme seems to be limited by the supply of
substrate, that is, AMP. It can be assumed that in the medium
simulating in vivo conditions, the rate of PNC practically depends
on the supply of AMP and/or activity of the AMPS synthetase. On
the other hand, in hypoxia, the efficiency of PNC can be improved
only if simultaneous activation of ATP generating processes
occurs. All these observations can be interpreted simply, as PNC
plays fundamental role in protecting the purine ring against
degradation. However, fact that the purine nucleotide cycle is still
very active in normoxic-like conditions implicates another physi-
ological significance for this cycle. That includes three possibili-
ties: (i) generation of ammonia for renal hydrogen ion excretion;
(ii) generation of ammonia and fumarate, which improves effi-
ciency and cooperativity between glycolysis and the Krebs cycle;
and (iii) regulation of tissue AMP level, the main source of
adenosine in the kidney.
The idea that PNC is an important source of renal ammonia
was proposed by Bogusky and Lowenstein [12, 29]. They have also
shown that activity of the key enzyme of PNC AMPS-synthetase
as well as AMPS-lyase increases several times in the kidneys of
acidotic and hypokalemic rats [301. Both disorders are known to
induce a significant increase in ammonia excretion. Otherwise,
experiments in vitro have questioned the possibility of ammonia
generation from glutamine or glutamate via the purine nucleotide
cycle [31—33]. However, the rate of aspartate production from
glutamate may be too low in vitro to protect the efficient activity of
PNC. The main reason is the Km value for aspartate in IMP
reamination, which in the kidney is relatively high and exceed 1
mM [9, 331. Therefore, it might be possible that PNC in vivo in the
kidney operates only when continuous blood delivery of aspartate
takes place. Functionally, such conditions are optimal in the initial
part of the nephron. The proximal tubule possesses the highest
efficiency of ammonia generation from glutamine and aspartate
[331, the highest activity of aspartate aminotransferase [33], and
potentially the continuous reabsorption of aspartate from ultra-
filtrate. Observations that levels of aspartate in renal tissue
(mainly cortex) is relatively high despite of its very low serum
concentration [34, 35] support such possibilities.
Improving the cooperation between glycolysis and the Krebs
cycle may be another important role of the purine nucleotide cycle
in kidney. PNC generates a substantial (up to 30% of renal
ammoniagenesis) quantity of ammonia and fumarate. Ammonia is
a strong activator of phosphofructokinase, a key enzyme of
glycolysis [36, 37] and inversely, 1,6-diphosphofructose inhibits
AMPS-synthase [38]. Indeed, precisely synchronized oscillations
in activities of glycolysis and PNC have been observed in muscles
[39, 40]. Consequently, generation of pyruvate with simultaneous
delivery of fumarate may decisively improve the efficiency of the
Krebs cycle. Such cooperation seems to be particularly important
for the renal medulla, where an increased risk of hypoxia is
assisted by a much higher efficiency of glycolysis than in the cortex
[41—43], activity of glycolytic key enzymes [42, 44], as well as
activity of purine nucleotide cycle [9, 10, 131. The observed
increase in the accumulation of aspartate and malate in medulla
after two minutes of anaerobiosis supports such a possibility [45].
At the very least, high activity of purine nucleotide cycle in
kidneys may be necessary to stabilize the tissue level of AMP.
AMP can be dephosphotylated by cytosolic 5'-nucleotidase to
adenosine, which seems to play a decisive role in glomerular
function [4—8] and in renal medullary oxygen balance [46].
Adenosine is mainly metabolized by adenosine deaminase, the
most active enzyme of purine catabolism in the kidney [28]. The
second enzyme, adenosine kinase, has shown the lowest activity
and a very low Km value for adenosine [13, 28], and therefore it
seems to be regulatory at a low adenosine concentration. It might
be concluded that rapid changes of adenosine levels in renal tissue
practically depend on the activity of cytosolic 5'-nucleotidase. In
view of the reported properties, all cytosolic 5'-NT can be divided
into 5'-NT (N-IT) with a higher affinity for IMP than AMP and
5'-NT (N-I) with a preference for AMP over IMP as a substrate
[47, 48]. N-I is activated by ADP but not ATP, in contrast to N-Il,
which is activated by ATP and less well by ADP. In our previous
report we showed that cytosol from kidney cortex and medulla
possesses low and high Km 5'-NT [13], which can be related to N-I
and N-Il, respectively. The increase in the AMP level in renal
tissue mainly depends on an excessive rate of ATP degradation
due to, for example, hypoxia or overload of transport processes; it
is particularly seen in the thick ascending loop of Henle. Based on
our data, the assumption can be made that purine nucleotide cycle
can effectively modulate dramatic changes in AMP concentration
in such situations, and indirectly affect the rate of adenosine
generation.
Reprint requests to Dr. Jan Stepinski, Department of Clinical Biochemistry,
Medical University of Gdansk, ul. Debinki 7, 80-211 Gdansk, Poland.
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